Akèy › Kansè Poumon ki pa ti selil › Alabama › Mobile
Etid klinik pou Kansè Poumon ki pa ti selil nan Mobile, AL
13 etid pou Kansè Poumon ki pa ti selil ap chèche patisipan nan sit nan ak bò kote Mobile (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Ap rekriteFaz 2/3
- Southern Cancer Center, P.C., Daphne · 10 mi lwen
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Ap rekriteFaz 3
- Southern Cancer Center Pc, Daphne · 10 mi lwen
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Ap rekriteFaz 3
- Southern Cancer Center Pc, Daphne · 10 mi lwen
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Ap rekriteFaz 3
- Southern Cancer Center, Daphne · 10 mi lwen
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Ap rekriteFaz 2
- Southern Cancer Center, PC, Daphne · 10 mi lwen
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Infirmary Cancer Care, Mobile
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Ap rekriteFaz 3
- Local Institution - 0487, Mobile
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Mobile Infirmary Medical Center, Mobile
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland, Saraland · 9 mi lwen
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne · 10 mi lwen
- ak 1 plis
MYLUNG Consortium Part 3: Observational Study
Ap rekriteEtid obsèvasyon
- Southern Cancer Center, PC, Daphne · 10 mi lwen
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2
- Mobile Infirmary Medical Center, Mobile
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland, Saraland · 9 mi lwen
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne · 10 mi lwen
- ak 1 plis
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Ap rekriteFaz 2/3
- Mobile Infirmary Medical Center, Mobile
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland, Saraland · 9 mi lwen
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne · 10 mi lwen
- ak 1 plis
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Ap rekrite
- University of South Alabama, Mobile
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Mobile
Etid Kansè Poumon ki pa ti selil nan lòt vil
- Houston, TX145 etid
- New York City, NY120 etid
- Arlington, VA104 etid
- Nashville, TN97 etid
- Boston, MA90 etid
- Los Angeles, CA87 etid
- St. Louis, MO73 etid
- Chicago, IL61 etid
- Baltimore, MD60 etid
- San Antonio, TX59 etid
- Columbus, OH56 etid
- Washington, DC55 etid
Lòt etid nan Mobile
- Ensifizyans kadyak13 etid
- Kansè poumon7 etid
- Kansè nan tete7 etid
- Kansè ovè7 etid
- Obèsite7 etid
- Kansè (tout kalite)6 etid
- Melanom6 etid
- Kansè poumon selil ti6 etid
- Maladi kadyovaskilè6 etid
- Fibrilasyon atriyal5 etid
- Sipwa5 etid
- Dyabèt Tip 25 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.